Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Eckstein, ML; Farinha, JB; McCarthy, O; West, DJ; Yardley, JE; Bally, L; Zueger, T; Stettler, C; Boff, W; Reischak-Oliveira, A; Riddell, MC; Zaharieva, DP; Pieber, TR; Müller, A; Birnbaumer, P; Aziz, F; Brugnara, L; Haahr, H; Zijlstra, E; Heise, T; Sourij, H; Roden, M; Hofmann, P; Bracken, RM; Pesta, D; Moser, O.
Differences in Physiological Responses to Cardiopulmonary Exercise Testing in Adults With and Without Type 1 Diabetes: A Pooled Analysis.
Diabetes Care. 2021; 44(1):240-247
Doi: 10.2337/dc20-1496
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Eckstein Max Lennart
-
Moser Othmar
- Co-authors Med Uni Graz
-
Aziz Faisal
-
Hofmann Peter
-
Müller Alexander
-
Pieber Thomas
-
Sourij Harald
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
To investigate physiological responses to cardiopulmonary exercise (CPX) testing in adults with type 1 diabetes compared with age-, sex-, and BMI-matched control participants without type 1 diabetes.
We compared results from CPX tests on a cycle ergometer in individuals with type 1 diabetes and control participants without type 1 diabetes. Parameters were peak and threshold variables of VO2, heart rate, and power output. Differences between groups were investigated through restricted maximum likelihood modeling and post hoc tests. Differences between groups were explained by stepwise linear regressions (P < 0.05).
Among 303 individuals with type 1 diabetes (age 33 [interquartile range 22; 43] years, 93 females, BMI 23.6 [22; 26] kg/m2, HbA1c 6.9% [6.2; 7.7%] [52 (44; 61) mmol/mol]), VO2peak (32.55 [26.49; 38.72] vs. 42.67 ± 10.44 mL/kg/min), peak heart rate (179 [170; 187] vs. 184 [175; 191] beats/min), and peak power (216 [171; 253] vs. 245 [200; 300] W) were lower compared with 308 control participants without type 1 diabetes (all P < 0.001). Individuals with type 1 diabetes displayed an impaired degree and direction of the heart rate-to-performance curve compared with control participants without type 1 diabetes (0.07 [-0.75; 1.09] vs. 0.66 [-0.28; 1.45]; P < 0.001). None of the exercise physiological responses were associated with HbA1c in individuals with type 1 diabetes.
Individuals with type 1 diabetes show altered responses to CPX testing, which cannot be explained by HbA1c. Intriguingly, the participants in our cohort were people with recent-onset type 1 diabetes; heart rate dynamics were altered during CPX testing.
© 2020 by the American Diabetes Association.